In fact, prior work in cirrhosis showed that higher CXCL9 levels predict poorer survival [30], supporting our findings that CXCL9 and CXCL10 better capture the injurious immune milieu in advanced ALD. This evidence concerns the gene CXCL9 and Cirrhosis.